Profil
Stephen Alister Locarnini is the founder of ClearB Therapeutics, Inc. (founded in 2017).
He currently holds the position of Independent Non-Executive Director at Biotron Ltd. since 2018 and is also a Professor at the University of Melbourne.
In the past, he served as the Director-Laboratory Services at the Victorian Infectious Diseases Reference Laboratory from 1990 to 1998 and as the Director at the World Health Organization Collaborating Centre.
Aktive Positionen von Stephen Locarnini
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOTRON LIMITED | Direktor/Vorstandsmitglied | 23.10.2018 |
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Stephen Locarnini
| Unternehmen | Position | Ende |
|---|---|---|
ClearB Therapeutics, Inc.
ClearB Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic vaccines for immune system | Gründer | - |
Victorian Infectious Diseases Reference Laboratory | Corporate Officer/Principal | - |
World Health Organization Collaborating Centre | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Biotron Ltd.
Biotron Ltd. BiotechnologyHealth Technology Operates as a biotechnology research and development company that manufactures anti-viral drugs | Health Technology |
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Victorian Infectious Diseases Reference Laboratory | |
World Health Organization Collaborating Centre | |
ClearB Therapeutics, Inc.
ClearB Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic vaccines for immune system | Health Technology |
















